Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
Leukemia & Lymphoma
|
December 30, 1998
Mini-ICE protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia
A M Carella
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
The place of high-dose therapy with autologous stem cell transplantation in primary treatment of Hodgkin's disease
A M Carella
Leukemia
|
April 4, 2008
Interferon-alpha is able to maintain complete molecular remission induced by imatinib after its discontinuation
A M Carella
Leukemia
|
May 10, 2000
Autografting with non-clonal mobilized hematopoietic progenitor cells in CML
A M Carella
Recenti Progressi in Medicina
|
June 21, 2001
[Hematopoietic stem cell transplantation after nonmyeloablative conditioning]
A M Carella
Leukemia
|
May 24, 2003
Questioning the aim of CML therapy in the era of Imatinib?
A M Carella
Haematologica
|
January 1, 1990
Autologous bone marrow transplantation in acute lymphoblastic leukemia: biological and clinical aspects
A M Carella
Leukemia & Lymphoma
|
January 1, 1992
Indications for autologous bone marrow transplantation in Hodgkin's disease
A M Carella
Haematologica
|
July 1, 1992
High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
A M Carella
Haematologica
|
November 1, 1990
Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia
A M Carella
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
Leukemia & Lymphoma
|
December 30, 1998
Mini-ICE protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia
A M Carella
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
The place of high-dose therapy with autologous stem cell transplantation in primary treatment of Hodgkin's disease
A M Carella
Leukemia
|
April 4, 2008
Interferon-alpha is able to maintain complete molecular remission induced by imatinib after its discontinuation
A M Carella
Leukemia
|
May 10, 2000
Autografting with non-clonal mobilized hematopoietic progenitor cells in CML
A M Carella
Recenti Progressi in Medicina
|
June 21, 2001
[Hematopoietic stem cell transplantation after nonmyeloablative conditioning]
A M Carella
Leukemia
|
May 24, 2003
Questioning the aim of CML therapy in the era of Imatinib?
A M Carella
Haematologica
|
January 1, 1990
Autologous bone marrow transplantation in acute lymphoblastic leukemia: biological and clinical aspects
A M Carella
Leukemia & Lymphoma
|
January 1, 1992
Indications for autologous bone marrow transplantation in Hodgkin's disease
A M Carella
Haematologica
|
July 1, 1992
High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
A M Carella
Haematologica
|
November 1, 1990
Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia
A M Carella
Page
of 16